Vehicle Safety
Recalls Search 320,000+ NHTSA safety recalls Complaints 2.1M+ consumer safety complaints TSBs 4.7M technical service bulletins VIN Lookup Decode any vehicle VIN instantly OBD Codes 12,000+ diagnostic trouble codes Fuel Economy EPA MPG data for all vehicles Safety Ratings 11,700+ NHTSA crash test ratings Investigations 5,300+ NHTSA defect investigations Statistics Recall trends & safety analysis
Consumer Safety
Product Safety 9,700+ CPSC product recalls Food Safety 28,600+ FDA food recalls Pet Safety 1.3M FDA animal adverse events Drug Safety 17,500+ FDA drug recalls Device Safety 38,400+ FDA device recalls Workplace Safety 102,900+ OSHA injury reports Brand History Cross-category recall lookup by company
Infrastructure
Bridge Safety 624,000 bridge inspections Aviation Safety 30,000+ NTSB aviation events Dam Safety 92,600 dam safety records Water Safety 433,000+ public water systems Railroad Safety 438,000+ rail crossings Pipeline Safety 8,800+ pipeline incidents State Safety Dashboards Safety grades for all 50 U.S. states ZIP Safety Report Check any 5-digit ZIP across 9 datasets
Public Health
Nursing Homes 14,700 CMS rated facilities Environmental 80,000+ hazardous sites & releases
Blog

Vehicle Safety

Vehicle Recalls320,000+ NHTSA safety recalls Browse VehiclesEvery make, model and year Complaints2.1M+ consumer safety complaints TSBs4.7M technical service bulletins VIN LookupDecode any vehicle VIN instantly OBD Codes12,000+ diagnostic trouble codes Fuel EconomyEPA MPG data for all vehicles Safety Ratings11,700+ NHTSA crash test ratings Investigations5,300+ NHTSA defect investigations StatisticsRecall trends & safety analysis Compare VehiclesTwo vehicles side by side

Consumer Safety

Product Safety9,700+ CPSC product recalls Food Safety28,600+ FDA food recalls Pet Safety1.3M FDA animal adverse events Drug Safety17,500+ FDA drug recalls Device Safety38,400+ FDA device recalls Workplace Safety102,900+ OSHA injury reports Brand HistoryRecall lookup by company

Infrastructure

Bridge Safety624,000 bridge inspections Aviation Safety30,000+ NTSB aviation events Dam Safety92,600 dam safety records Water Safety433,000+ public water systems Railroad Safety438,000+ rail crossings Pipeline Safety8,800+ pipeline incidents State DashboardsSafety grades for all 50 states ZIP ReportAny 5-digit ZIP across 9 datasets

Public Health

Nursing Homes14,700 CMS rated facilities Environmental80,000+ hazardous sites & releases BlogGuides, news & safety insights

Clinical Specialties Compounding Pharmacy

Complete recall history across all FDA and CPSC categories — 50 total recalls

Clinical Specialties Compounding Pharmacy appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.

Drug Recalls (50)

FDA drug safety enforcement actions by Clinical Specialties Compounding Pharmacy

Date Product Reason Class
Mar 20, 2013 Test cyp 35 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 HCG 2000 units/ml, 30 mL syringe, Clinical Specialties Compounding Pharmacy, ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Itraconazole 1% eye ointment, Clinical Specialties Compounding Pharmacy, 318 ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Test Cyp 250 mg-lidocaine 5 mg/ml, Clinical Specialties Compounding Pharmacy,... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Test Cyp 50 mg-estradiol cyp 2 mg/ml, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Test cyp 25 mg-Estradiol cyp 5 mg/ml, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 HCG 500 units/ml, 10 mL syringe, Clinical Specialties Compounding Pharmacy, 3... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Test cyp 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 HCG 1000 units/ml, 30 mL syringe, Clinical Specialties Compounding Pharmacy, ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Cyclosporine 1% ophthalmic drops, Clinical Specialties Compounding Pharmacy, ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Test cyp 75 mg-estradiol cyp 5 mg/ml, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Test cyp 25 mg-Estadiol valerate 15 mg/mL, Clinical Specialties Compounding P... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Cyclosporine 2% ophthalmic, Clinical Specialties Compounding Pharmacy, 318 Ba... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Cataract drops, Clinical Specialties Compounding Pharmacy, 318 Baston Road, A... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Laser ophthalmic drops, 12 mL bottle, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Test Cyp 200 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Roa... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Test Cyp 100 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Roa... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Test Cyp 10 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Test cyp 25 mg-estradiol cyp 7 mg/ml, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Acetylcysteine 20 % solution, 100 ml bottle, Clinical Specialties Compounding... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Pap 300 mg-phent 10 mg-prost 100 mcg, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Hydroxyprogesterone 250 mg/ml, Clinical Specialties Compounding Pharmacy, 318... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Estradiol Cypionate 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 B... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Estradiol Valerate 30 mg/ml, Clinical Specialties Compounding Pharmacy, 318 B... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Latanoprost 0.025% eye drop, Clinical Specialties Compounding Pharmacy, 318 B... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Methionine/Choline/Inositol/ B-12, Clinical Specialties Compounding Pharmacy,... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Medroxyprogesterone 150 mg/ml,Clinical Specialties Compounding Pharmacy, 318 ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Diazepam 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road,... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Gentamicin buffered 36.4 mg/ml, Clinical Specialties Compounding Pharmacy, 31... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Acetylcysteine 10 % Solution, Clinical Specialties Compounding Pharmacy, 318 ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Acetylcysteine 2 % Solution, Clinical Specialties Compounding Pharmacy, 318 ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Tetracaine(buffered) 0.25% solution, Clinical Specialties Compounding Pharmac... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Test Cyp 50 mg-estradiol cyp 7 mg/ml, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Test Cyp 25 mg-e(2) blend 12 mg/ml, Clinical Specialties Compounding Pharmacy... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Estradiol Valerate 20 mg/ml, Clinical Specialties Compounding Pharmacy, 318 B... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Medroxyprogesterone 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Mitomycin (modified) 0.02% solution, Clinical Specialties Compounding Pharmac... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Ophthalmic dilation gel, Clinical Specialties Compounding Pharmacy, 318 Basto... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Sodium Chloride (23.4%), Clinical Specialties Compounding Pharmacy, 318 Basto... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Phenylephrine-cyclopentolate, Clinical Specialties Compounding Pharmacy, 318 ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Mitomycin 0.04% solution, Clinical Specialties Compounding Pharmacy, 318 Bast... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Ophthalmic dilation gel (MAR), Clinical Specialties Compounding Pharmacy, 318... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Methylcobalamin 1250 mcg/ml, Clinical Specialties Compounding Pharmacy, 318 ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Injection vehicle, 120 ml, Clinical Specialties Compounding Pharmacy, 318 Bas... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Vancomycin 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Ro... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Methylcobalamin 12.5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Ba... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Test Cyp 50 mg-estradiol blend 22 mg, Clinical Specialties Compounding Pharma... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 20, 2013 Progesterone 50 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston ... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
Mar 11, 2013 Avastin, (0.05 ml, 1.25 mg/0.05ml), single unit dose syringes, Clinical Speci... Lack of Assurance of Sterility; product linked to adverse event reports of en... Class II

Frequently Asked Questions

A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.

Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.

The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.

Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.

Explore More Recalls

Search recalls by category, state, reason, or firm across all our databases.

Food Firms Drug Firms Device Firms Product Manufacturers